ArticleACS omega2025
Fabrication of Au Nanostructured Thin Film via Femtosecond Laser Glass Texturing for Enhanced Glucose Sensing.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate glucose sensing is crucial for diabetes management, with nonenzymatic electrochemical devices promising enhanced durability and sensitivity. Nonetheless, widespread commercialization remains challenging, with the market still being dominated by their enzymatic counterparts. This study reports on the feasibility of femtosecond-laser texturing of glass followed by thin gold layer deposition to create a highly active and microchip-compatible glucose sensing platform. The laser treatment enables significant nanostructuring of the glass substrate, remarkably resulting in an 8 times greater surface area compared to flat gold films on glass. The electrodes were calibrated via both potentiostatic and potentiodynamic techniques. The laser-treated electrodes displayed in chronoamperometry a sensitivity to glucose of 63.9 ± 1.2 μA·cm
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.